Lumosa Therapeutics Co., Ltd. Share Price
Equities
6535
TW0006535008
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
172 TWD | 0.00% | -5.23% | +151.83% |
Sales 2024 * | 65M 2M 167M | Sales 2025 * | 1.57B 48.29M 4.03B | Capitalization | 28.38B 873M 72.8B |
---|---|---|---|---|---|
Net income 2024 * | -401M -12.34M -1.03B | Net income 2025 * | 786M 24.18M 2.02B | EV / Sales 2024 * | 433 x |
Net cash position 2024 * | 259M 7.97M 665M | Net cash position 2025 * | 954M 29.35M 2.45B | EV / Sales 2025 * | 17.5 x |
P/E ratio 2024 * |
-70.8
x | P/E ratio 2025 * |
36.1
x | Employees | 47 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.28% |
1 week | -5.23% | ||
Current month | -3.37% | ||
1 month | -3.91% | ||
3 months | +40.41% | ||
6 months | +186.19% | ||
Current year | +151.83% |
Managers | Title | Age | Since |
---|---|---|---|
Jung Chin Lin
CEO | Chief Executive Officer | 70 | 16/11/16 |
Chia Chi Yang
DFI | Director of Finance/CFO | - | 01/22/01 |
June Kuo
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Wan Lai Cheng
BRD | Director/Board Member | - | 25/14/25 |
Jung Chin Lin
CEO | Chief Executive Officer | 70 | 16/11/16 |
I Hsiung Chang
BRD | Director/Board Member | - | 26/16/26 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 172 | 0.00% | 552 671 |
26/24/26 | 172 | +0.29% | 473,636 |
25/24/25 | 171.5 | -4.19% | 655,161 |
24/24/24 | 179 | +6.55% | 543,185 |
23/24/23 | 168 | +0.90% | 804,508 |
End-of-day quote Taipei Exchange, April 29, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+151.83% | 870M | |
-2.85% | 103B | |
+1.58% | 95.28B | |
+1.46% | 22.15B | |
-16.14% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.28% | 16.05B | |
+5.54% | 13.68B | |
+33.04% | 12.17B |
- Stock Market
- Equities
- 6535 Stock